Automation, Monitoring, and Standardization of Cell Product Manufacturing
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Although regenerative medicine products are at the forefront of scientific research, technological innovation, and clinical translation, their reproducibility and large-scale production are compromised by automation, monitoring, and standardization issues. To overcome these limitations, new technologies at software (e.g., algorithms and artificial intelligence models, combined with imaging software and machine learning techniques) and hardware (e.g., automated liquid handling, automated cell expansion bioreactor systems, automated colony-forming unit counting and characterization units, and scalable cell culture plates) level are under intense investigation. Automation, monitoring and standardization should be considered at the early stages of the developmental cycle of cell products to deliver more robust and effective therapies and treatment plans to the bedside, reducing healthcare expenditure and improving services and patient care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Advances in machine learning have provided the means to assess large quantities of multi-dimensional datasets with the aim of developing predictive models and intervention strategies for biological systems79–81.”
From Induced pluripotency in the context of stem cell expansion bioprocess development, optimization, and manufacturing: a roadmap to the clinic (2021) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.023 · Cited by 7,283 · cited 1×
“3D cell culture systems: The case of pancreatic islet cell clusters for type I diabetes Diabetes affects globally > 382 million individuals with expected increase almost to 600 million in the next 15 years (Guariguata et al., 2014; Cho et al., 2018).”
BackgroundGlobal estimates of diabetes prevalence for 2013 and projections for 2035
Guariguata, L., Whiting, D. R., Hambleton, I., Beagley, J., Linnenkamp, U., & Shaw, J. E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.002 · Cited by 4,642 · cited 2×
“diabetes is the main cause for kidney disease with a correlation of 25 % of diabetic people resulting in kidney failure (Guariguata et al., 2014; Marshall, 2014).”
BackgroundThree-dimensional in vitro cell culture models in drug discovery and drug repositioning
Langhans, S. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00006 · Cited by 1,522
Zanoni, M., Piccinini, F., Arienti, C., Zamagni, A., Santi, S., Polico, R., Bevilacqua, A., & Tesei, A. (2016) · Scientific Reports · doi:10.1038/srep19103 · Cited by 1,144 · cited 1×
“, 2012) and constitute the first choice in cancer models and evaluation of anti-cancer drugs (Chatzinikolaidou, 2016; Zanoni et al., 2016; Rodrigues et al., 2018).”
BackgroundCRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Dever, D. P., Bak, R. O., Reinisch, A., Camarena, J., Washington, G., Nicolas, C. E., Pavel-Dinu, M., Saxena, N., Wilkens, A. B., Mantri, S., et al. (2016) · Nature · doi:10.1038/nature20134 · Cited by 864 · cited 2×
“Given the current guidelines for quality and process control for all types of manipulated HSCs, advancement of HSPC-based cellular therapies will certainly depend increasingly on the use of standardized potency assays, such as the CFU assay, especially when these cells are modified through CRISPR/Cas9 targeting prior…”
MethodVan Valen, D. A., Kudo, T., Lane, K. M., Macklin, D. N., Quach, N. T., DeFelice, M. M., Maayan, I., Tanouchi, Y., Ashley, E. A., & Covert, M. W. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005177 · Cited by 557
Tissue Engineering and Cell-Based Therapies for Fractures and Bone Defects
Perez, J. R., Kouroupis, D., Li, D. J., Best, T. M., Kaplan, L., & Correa, D. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00105 · Cited by 390 · cited 2×
“Introduction Cell and cell-based tissue engineering products have an extraordinary clinical potential by offering unique therapeutic solutions to disease conditions without any effective treatments yet, such as noncurable cancers or non-healing or hard to heal tissues (Perez et al., 2018; Abreu et al., 2019).”
BackgroundCardiac spheroids as promising in vitro models to study the human heart microenvironment
Polonchuk, L., Chabria, M., Badi, L., Hoflack, J.-C., Figtree, G., Davies, M. J., & Gentile, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-06385-8 · Cited by 223
Emerging tumor spheroids technologies for 3D in vitro cancer modeling
Rodrigues, T., Kundu, B., Silva-Correia, J., Kundu, S. C., Oliveira, J. M., Reis, R. L., & Correlo, V. M. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.018 · Cited by 178 · cited 1×
“, 2012) and constitute the first choice in cancer models and evaluation of anti-cancer drugs (Chatzinikolaidou, 2016; Zanoni et al., 2016; Rodrigues et al., 2018).”
BackgroundThe journey of islet cell transplantation and future development
Gamble, A., Pepper, A. R., Bruni, A., & Shapiro, A. M. J. (2018) · Islets · doi:10.1080/19382014.2018.1428511 · Cited by 171 · cited 2×
“should be addressed to alleviate islet cell loss and to improve engraftment outcomes (Shapiro et al., 2017; Gamble et al., 2018).”
BackgroundInsulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes
Lebreton, F., Lavallard, V., Bellofatto, K., Bonnet, R., Wassmer, C. H., Perez, L., Kalandadze, V., Follenzi, A., Boulvain, M., Kerr-Conte, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12472-3 · Cited by 157 · cited 1×
“Recent data however study demonstrated that incorporation of human amniotic epithelial cells into islet organoids to markedly enhance engraftment, viability and graft function in a mouse type 1 diabetes model (Lebreton et al., 2019).”
BackgroundLong-term maintenance of human induced pluripotent stem cells by automated cell culture system
Konagaya, S., Ando, T., Yamauchi, T., Suemori, H., & Iwata, H. (2015) · Scientific Reports · doi:10.1038/srep16647 · Cited by 94
The Future of Islet Transplantation Is Now
Bottino, R., Knoll, M. F., Knoll, C. A., Bertera, S., & Trucco, M. M. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00202 · Cited by 93
Hilderink, J., Spijker, S., Carlotti, F., Lange, L., Engelse, M., van Blitterswijk, C., de Koning, E., Karperien, M., & van Apeldoorn, A. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12555 · Cited by 83
Hamad, S., Derichsweiler, D., Papadopoulos, S., Nguemo, F., Šarić, T., Sachinidis, A., Brockmeier, K., Hescheler, J., Boukens, B. J., & Pfannkuche, K. (2019) · Theranostics · doi:10.7150/thno.32058 · Cited by 83
Sailem, H. Z., Rittscher, J., & Pelkmans, L. (2020) · Molecular Systems Biology · doi:10.15252/msb.20199083 · Cited by 16 · cited 1×
“Indeed, image processing machine learning techniques have been successfully implemented and validated in oncological studies to predict specific function based on gene phenotype similarities (Sailem et al., 2020), in predicting cell growth per passage from batches obtained from donors varying in age (Mehrian et al.”
Method
Research works printed but not linked: 95
- Abreu, 2019, Current challenges and emerging opportunities of CAR-T cell therapies., J. Control. Release, 319, 246, 10.1016/j.jconrel.2019.12.047 · DOI
- Aijaz, 2018, Biomanufacturing for clinically advanced cell therapies., Nat. Biomed. Eng., 2, 362, 10.1038/s41551-018-0246-6 · DOI · Paper page
- Anitha, 2020, Tissue-engineered islet-like cell clusters generated from adipose tissue-derived stem cells on three-dimensional electrospun scaffolds can reverse diabetes in an experimental rat model and the role of porosity of scaffolds on cluster differentiation., J. Biomed. Mater. Res. A, 108, 749, 10.1002/jbm.a.36854 · doi:10.1002/jbm.a.36854
- Ball, 2018, Bioprocessing automation in cell therapy manufacturing: outcomes of special interest group automation workshop., Cytotherapy, 20, 592, 10.1016/j.jcyt.2018.01.005 · doi:10.1016/j.jcyt.2018.01.005
- Bhang, 2012, Transplantation of cord blood mesenchymal stem cells as spheroids enhances vascularization., Tissue Eng. A, 18, 2138, 10.1089/ten.tea.2011.0640 · DOI · Paper page
- Boutros, 2015, Microscopy-based high-content screening., Cell, 163, 1314, 10.1016/j.cell.2015.11.007 · DOI · Paper page
- Boyer, 2018, High-throughput scaffold-free microtissues through 3D printing., 3D Print. Med., 4, 10.1186/s41205-018-0029-4 · DOI
- Brandhorst, 2016, High seeding density induces local hypoxia and triggers a proinflammatory response in isolated human islets., Cell Transplant., 25, 1539, 10.3727/096368915x689929 · DOI
- Buskermolen, 2018, An automated quantitative analysis of cell, nucleus and focal adhesion morphology., PLoS One, 13, 10.1371/journal.pone.0195201 · DOI
- Cesarz, 2016, Spheroid culture of mesenchymal stem cells., Stem Cells Int., 2016, 10.1155/2016/9176357 · DOI · Paper page
- Chang, 2018, Crosslinked chitosan-PEG hydrogel for culture of human glioblastoma cell spheroids and drug screening., Adv. Ther., 1, 10.1002/adtp.201800058 · DOI
- Chatzinikolaidou, 2016, Cell spheroids: the new frontiers in in vitro models for cancer drug validation., Drug Discov. Today, 21, 1553, 10.1016/j.drudis.2016.06.024 · DOI
- Cierpka-Kmiec, 2019, In vitro generation of pancreatic β-cells for diabetes treatment. I. β-like cells derived from human pluripotent stem cells., Folia Histochem. Cytobiol., 57, 1
- Cigognini, 2013, Engineering in vitro microenvironments for cell based therapies and drug discovery., Drug Discov. Today, 18, 1099, 10.1016/j.drudis.2013.06.007 · DOI
- Colle, 2020, Bioprinting predifferentiated adipose-derived mesenchymal stem cell spheroids with methacrylated gelatin ink for adipose tissue engineering., J. Mater. Sci. Mater. Med., 31, 10.1007/s10856-020-06374-w · DOI
- Costariol, 2019, Establishing the scalable manufacture of primary human T-cells in an automated stirred-tank bioreactor., Biotechnol. Bioeng., 116, 2488, 10.1002/bit.27088 · DOI · Paper page
- de Sousa Pinto, 2019, Scalable manufacturing of human mesenchymal stromal cells in the vertical-wheel bioreactor system: an experimental and economic approach., Biotechnol. J., 14, 10.1002/biot.201800716 · DOI
- DeFilipp, 2019, Hematopoietic cell transplantation in the treatment of adult acute lymphoblastic leukemia: updated 2019 evidence-based review from the American Society for Transplantation and Cellular Therapy., Biol. Blood Marrow Transplant., 25, 2113, 10.1016/j.bbmt.2019.08.014 · DOI
- Fu, 2013, Regulation of insulin synthesis and secretion and pancreatic beta-cell dysfunction in diabetes., Curr. Diabetes Rev., 9, 25, 10.2174/157339913804143225 · DOI · Paper page
- 2018, Cell Therapy Market Size, Share, & Trends Analysis Report by Use (Clinical, Research), by Type (Stem & Non-Stem Cells) by Therapy Type (Autologous, Allogenic), by Region, and Segment Forecasts, 2018 –2025.
- Gutzweiler, 2017, Large scale production and controlled deposition of single HUVEC spheroids for bioprinting applications., Biofabrication, 9, 10.1088/1758-5090/aa7218 · DOI
- Hagemann, 2017, Spheroid-based 3D cell cultures enable personalized therapy testing and drug discovery in head and neck cancer., Anticancer Res., 37, 2201, 10.21873/anticanres.11555 · DOI · Paper page
- Harrison, Cell therapy-processing economics: small-scale microfactories as a stepping stone toward large-scale macrofactories., Regen. Med., 13, 159, 10.2217/rme-2017-0103 · DOI
- Harrison, Decentralised manufacturing of cell and gene therapy products: learning from other healthcare sectors., Biotechnol. Adv., 36, 345, 10.1016/j.biotechadv.2017.12.013 · DOI · Paper page
- Hunsberger, 2018, An industry-driven roadmap for manufacturing in regenerative medicine., Stem Cells Transl. Med., 7, 564, 10.1002/sctm.18-0060 · DOI · Paper page
- Ichihara, 2016, Size effect of engineered islets prepared using microfabricated wells on islet cell function and arrangement., Heliyon, 2, 10.1016/j.heliyon.2016.e00129 · DOI
- Jung, 2018, Highly modular and generic control software for adaptive cell processing on automated production platforms., Procedia CIRP, 72, 1245, 10.1016/j.procir.2018.03.189 · DOI
- Juric, 2016, Milestones of hematopoietic stem cell transplantation - From first human studies to current developments., Front. Immunol., 7, 10.3389/fimmu.2016.00470 · DOI
- Kanafi, 2013, Transplantation of islet-like cell clusters derived from human dental pulp stem cells restores normoglycemia in diabetic mice., Cytotherapy, 15, 1228, 10.1016/j.jcyt.2013.05.008 · DOI
- Kapur, 2012, Human adipose stem cells maintain proliferative, synthetic and multipotential properties when suspension cultured as self-assembling spheroids., Biofabrication, 4, 10.1088/1758-5082/4/2/025004 · DOI
- Kettunen, 2020, Human physiology of genetic defects causing beta-cell dysfunction., J. Mol. Biol., 432, 1579, 10.1016/j.jmb.2019.12.038 · DOI
- Kim, 2019, Fabrication of core-shell spheroids as building blocks for engineering 3D complex vascularized tissue., Acta Biomater., 100, 158, 10.1016/j.actbio.2019.09.028 · DOI
- Kong, 2012, Automatic liquid handling for life science: a critical review of the current state of the art., J. Lab. Autom., 17, 169, 10.1177/2211068211435302 · DOI · Paper page
- Kumar, 2019, Applications of stem cells and bioprinting for potential treatment of diabetes., World J. Stem Cells, 11, 13, 10.4252/wjsc.v11.i1.13 · DOI
- Labuschagne, 2019, Cell clustering promotes a metabolic switch that supports metastatic colonization., Cell Metab., 30, 720, 10.1016/j.cmet.2019.07.014 · DOI · Paper page
- Lam, 2019, Machine learning with optical phase signatures for phenotypic profiling of cell lines., Cytometry A, 95, 757, 10.1002/cyto.a.23774 · DOI
- Langer, 2020, Rapid production and recovery of cell spheroids by automated droplet microfluidics., SLAS Technol., 25, 111, 10.1177/2472630319877376 · DOI
- Lee, 2018, Generation of uniform-sized multicellular tumor spheroids using hydrogel microwells for advanced drug screening., Sci. Rep., 8, 10.1038/s41598-018-35216-7 · DOI · Paper page
- Lehmann, 2016, Biomek cell workstation: a variable system for automated cell cultivation., J. Lab. Autom., 21, 439, 10.1177/2211068215599786 · DOI
- Lehmann, 2007, Superiority of small islets in human islet transplantation., Diabetes Metab. Res. Rev., 56, 594
- Lilly, 2016, Current stem cell based therapies in diabetes., Am. J. Stem Cells, 5, 87
- Lippi, 2017, Estimating the intra- and inter-individual imprecision of manual pipetting., Clin. Chem. Lab. Med., 55, 962, 10.1515/cclm-2016-0810 · DOI
- Lipsitz, 2017, A roadmap for cost-of-goods planning to guide economic production of cell therapy products., Cytotherapy, 19, 1383, 10.1016/j.jcyt.2017.06.009 · DOI
- Liu, 2017, Nano-on-micro fibrous extracellular matrices for scalable expansion of human ES/iPS cells., Biomaterials, 124, 47, 10.1016/j.biomaterials.2017.01.039 · DOI
- Lo, 2019, Growing human dermal fibroblasts as spheroids renders them susceptible for early expression of pluripotency genes., Adv. Biosyst., 3, 10.1002/adbi.201900094 · DOI
- Logan, 2016, Quantifying co-cultured cell phenotypes in high-throughput using pixel-based classification., Methods, 96, 6, 10.1016/j.ymeth.2015.12.002 · DOI
- Ly, 2013, Automated reagent-dispensing system for microfluidic cell biology assays., J. Lab. Autom., 18, 530, 10.1177/2211068213504758 · doi:10.1177/2211068213504758
- Maddah, 2014, A system for automated, noninvasive, morphology-based evaluation of induced pluripotent stem cell cultures., J. Lab. Autom., 19, 454, 10.1177/2211068214537258 · DOI
- Marshall, 2014, Preventing kidney failure in people with diabetes., Diabet. Med., 31, 1280, 10.1111/dme.12535 · DOI
- Mehrian, 2020, Predicting in vitro human mesenchymal stromal cell expansion based on individual donor characteristics using machine learning., Cytotherapy, 22, 82, 10.1016/j.jcyt.2019.12.006 · DOI
- Mitchell, 2017, Reproducing cells is nothing new—A historical perspective, Bioprinting: Techniques and Risks for Regenerative Medicine, 10.1016/B978-0-12-805369-0.00002-X · DOI
- Miyamoto, 2017, Enhanced adipogenic differentiation of human adipose-derived stem cells in an in vitro microenvironment: the preparation of adipose-like microtissues using a three-dimensional culture., Cell Med., 9, 35, 10.3727/215517916X693096 · DOI
- Moritani, 2018, Spheroid culture enhances osteogenic potential of periodontal ligament mesenchymal stem cells., J. Periodontal Res., 53, 870, 10.1111/jre.12577 · DOI
- Moritz, 2002, Apoptosis in hypoxic human pancreatic islets correlates with HIF-1α expression., FASEB J., 16, 745, 10.1096/fj.01-0403fje · DOI · Paper page
- Morrow, 2017, Addressing pressing needs in the development of advanced therapies., Front. Bioeng. Biotechnol., 5, 10.3389/fbioe.2017.00055 · doi:10.3389/fbioe.2017.00055
- Moutsatsou, 2019, Automation in cell and gene therapy manufacturing: from past to future., Biotechnol. Lett., 41, 1245, 10.1007/s10529-019-02732-z · DOI · Paper page
- Murphy, 2014, Human mesenchymal stem cell spheroids in fibrin hydrogels exhibit improved cell survival and potential for bone healing., Cell Tissue Res., 357, 91, 10.1007/s00441-014-1830-z · DOI
- Nagasaka, 2017, Image-based cell quality evaluation to detect irregularities under same culture process of human induced pluripotent stem cells., J. Biosci. Bioeng., 123, 642, 10.1016/j.jbiosc.2016.12.015 · doi:10.1016/j.jbiosc.2016.12.015
- Naldini, 2019, Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives., EMBO Mol. Med., 11, 10.15252/emmm.201809958 · DOI · Paper page
- Oh, 2018, Highly angiogenic, nonthrombogenic bone marrow mononuclear cell-derived spheroids in intraportal islet transplantation., Diabetes Metab. Res. Rev., 67, 473
- Ong, 2018, In vivo therapeutic applications of cell spheroids., Biotechnol. Adv., 36, 494, 10.1016/j.biotechadv.2018.02.003 · DOI
- Orita, 2019, Deep learning-based quality control of cultured human-induced pluripotent stem cell-derived cardiomyocytes., J. Pharmacol. Sci., 140, 313, 10.1016/j.jphs.2019.04.008 · DOI
- Page, 2011, Total colony-forming units are a strong, independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants., Biol. Blood Marrow Transplant., 17, 1362, 10.1016/j.bbmt.2011.01.011 · DOI · Paper page
- Pamphilon, 2013, Current practices and prospects for standardization of the hematopoietic colony-forming unit assay: a report by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative., Cytotherapy, 15, 255, 10.1016/j.jcyt.2012.11.013 · doi:10.1016/j.jcyt.2012.11.013
- Papas, 2019, Oxygenation strategies for encapsulated islet and beta cell transplants., Adv. Drug Deliv. Rev., 139, 139, 10.1016/j.addr.2019.05.002 · DOI · Paper page
- Peddi, 2007, High-throughput automated system for crystallizing membrane proteins in lipidic mesophases., IEEE Trans. Autom. Sci. Eng., 4, 129, 10.1109/TASE.2006.880541 · doi:10.1109/tase.2006.880541
- Peroglio, 2018, Relevance of bioreactors and whole tissue cultures for the translation of new therapies to humans., J. Orthop. Res., 36, 10, 10.1002/jor.23655 · DOI
- Petrenko, 2017, The therapeutic potential of three-dimensional multipotent mesenchymal stromal cell spheroids., Stem Cell Res. Ther., 8, 10.1186/s13287-017-0558-6 · DOI · Paper page
- Pietsch, 2017, Three-dimensional growth of human endothelial cells in an automated cell culture experiment container during the SpaceX CRS-8 ISS space mission - The SPHEROIDS project., Biomaterials, 124, 126, 10.1016/j.biomaterials.2017.02.005 · DOI
- Pigeau, 2018, Commercial scale manufacturing of allogeneic cell therapy., Front. Med., 5, 10.3389/fmed.2018.00233 · DOI
- Porterfield, 2000, Oxygen consumption oscillates in single clonal pancreatic beta-cells (HIT)., Diabetes Metab. Res. Rev., 49, 1511
- Prasad, 2008, Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes., Blood, 112, 2979, 10.1182/blood-2008-03-140830 · DOI · Paper page
- Radio, 2018, Neuronal cell morphology in primary cerebellar granule cells using high-content analysis., Methods Mol. Biol., 1727, 227, 10.1007/978-1-4939-7571-6_17 · doi:10.1007/978-1-4939-7571-6_17
- Rawal, 2017, Integration of mesenchymal stem cells into islet cell spheroids improves long-term viability, but not islet function., Islets, 9, 87, 10.1080/19382014.2017.1341455 · DOI
- Rothmiller, 2020, Validation of automated pipetting systems for cell culture seeding, exposure and bio-analytical assays in sulfur mustard toxicology., Toxicol. Lett., 320, 80, 10.1016/j.toxlet.2019.12.003 · doi:10.1016/j.toxlet.2019.12.003
- Ruiz, 2019, Robust generation of erythroid and multilineage hematopoietic progenitors from human iPSCs using a scalable monolayer culture system., Stem Cell Res., 41, 10.1016/j.scr.2019.101600 · DOI
- Schmidhauser, 2019, Gaining insights into the function of post-translational protein modification using genome engineering and molecular cell biology., J. Mol. Biol., 431, 3920, 10.1016/j.jmb.2019.07.015 · DOI
- Schrock, 2017, A cost-effectiveness analysis of surgical treatment modalities for chondral lesions of the knee: microfracture, osteochondral autograft transplantation, and autologous chondrocyte implantation., Orthop. J. Sports Med., 5, 10.1177/2325967117704634 · DOI
- Schulze-Tanzil, 2020, SV40 transfected human anterior cruciate ligament derived ligamentocytes - Suitable as a human in vitro model for ligament reconstruction?, Int. J. Mol. Sci., 21, 10.3390/ijms21020593 · DOI
- Serra, 2019, Scalable culture strategies for the expansion of patient-derived cancer stem cell lines., Stem Cells Int., 2019, 10.1155/2019/8347595 · DOI
- Shapiro, 2017, Clinical pancreatic islet transplantation., Nat. Rev. Endocrinol., 13, 268, 10.1038/nrendo.2016.178 · DOI · Paper page
- Stephenson, 2018, Recent advances in bioreactors for cell-based therapies., F1000Res., 7, 10.12688/f1000research.12533.1 · DOI
- Suszynski, 2016, Oxygenation of the intraportally transplanted pancreatic islet., J. Diabetes Res., 2016, 10.1155/2016/7625947 · DOI · Paper page
- Takami, 2018, Hematopoietic stem cell transplantation for acute myeloid leukemia., Int. J. Hematol., 107, 513, 10.1007/s12185-018-2412-8 · doi:10.1007/s12185-018-2412-8
- Tsai, 2019, Enhancement of human adipose-derived stem cell spheroid differentiation in an in situ enzyme-crosslinked gelatin hydrogel., J. Mater. Chem. B, 7, 1064, 10.1039/C8TB02835D · DOI
- Van Hoof, 2011, Differentiation of human embryonic stem cells into pancreatic endoderm in patterned size-controlled clusters., Stem Cell Res., 6, 276, 10.1016/j.scr.2011.02.004 · DOI · Paper page
- Velier, 2019, Validation of a semi automatic device to standardize quantification of Colony-Forming Unit (CFU) on hematopoietic stem cell products., Cytotherapy, 21, 820, 10.1016/j.jcyt.2019.06.005 · doi:10.1016/j.jcyt.2019.06.005
- Vlahos, 2019, Endothelialized collagen based pseudo-islets enables tuneable subcutaneous diabetes therapy., Biomaterials, 232
- Vormittag, 2018, A guide to manufacturing CAR T cell therapies., Curr. Opin. Biotechnol., 53, 164, 10.1016/j.copbio.2018.01.025 · DOI · Paper page
- Wakui, 2017, Method for evaluation of human induced pluripotent stem cell quality using image analysis based on the biological morphology of cells., J. Med. Imaging, 4, 10.1117/1.JMI.4.4.044003 · doi:10.1117/1.jmi.4.4.044003
- Watts, 2016, Optimisation and quality control of cell processing for autologous stem cell transplantation., Br. J. Haematol., 175, 771, 10.1111/bjh.14378 · doi:10.1111/bjh.14378
- Yamaguchi, 2014, Mesenchymal stem cell spheroids exhibit enhanced in-vitro and in-vivo osteoregenerative potential., BMC Biotechnol., 14, 10.1186/s12896-014-0105-9 · DOI · Paper page
- Yaxin, 2011, Robotic liquid handling system for microdispensing of highly viscous reagent, Proceedings of the Third International Conference on Measuring Technology and Mechatronics Automation, 10.1109/ICMTMA.2011.614 · doi:10.1109/icmtma.2011.614
- Yoon, 2012, Enhanced cartilage formation via three-dimensional cell engineering of human adipose-derived stem cells., Tissue Eng. A, 18, 1949, 10.1089/ten.tea.2011.0647 · DOI
- Zuppinger, 2019, 3D cardiac cell culture: a critical review of current technologies and applications., Front. Cardiovasc. Med., 6, 10.3389/fcvm.2019.00087 · DOI · Paper page
Cited by
Colter, J., Murari, K., Biernaskie, J., & Kallos, M. S. (2021) · npj Regenerative Medicine · doi:10.1038/s41536-021-00183-7 · Cited by 33
Metadata
- Authors
- Doulgkeroglou, M.-N., Di Nubila, A., Niessing, B., König, N., Schmitt, R. H., Damen, J., Szilvassy, S. J., Chang, W., Csontos, L., Louis, S., Kugelmeier, P., Ronfard, V., Bayon, Y., & Zeugolis, D. I.
- Venue
- Frontiers in Bioengineering and Biotechnology
- Publisher
- Frontiers Media SA
- Published
- 2020-07-14
- Volume
- 8
- ISSN
- 2296-4185
- Cited by
- 98
- References
- 16
- Funders
- Science Foundation Ireland (15/CDA/3629, 13/RC/2073)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.